ELAN-Pilot Projects

P165-OA: Lipid nanoparticles for targeted delivery of HIV-1 antigens and genetic immunomodulators Jan. 1, 2025 - Dec. 31, 2025 P154-OA: Establishing an in vitro negative-pressure wound therapy (NPWT) model and analysing molecular effects of NPWT Jan. 1, 2025 - Dec. 31, 2025 P149: Podocyte specific targeting with functionalized drug loaded nanoparticles for precision medicine Jan. 1, 2025 - Dec. 31, 2025 P145: Impaired local and systemic Th17/Treg immune response in periodontitis July 1, 2024 - Dec. 31, 2025 P139: Modulation of Pain Perception by 3-Indolepropionic Acid in Arthritis: Implications for the Clinical Course June 16, 2024 - Dec. 15, 2025 P166: Role of C-terminal Binding Protein 1 (CTBP1) in Hippocampal Energetics Dec. 1, 2024 - Nov. 30, 2025 P151-OA: Nephronectin-Integrin: From podocyte nephronectin secretion into the ECM and back to podocyte integrity Oct. 1, 2024 - Sept. 30, 2025 P170: The impact of BC 007 on immune dysregulation in patients with Post-COVID syndrome Feb. 1, 2025 - Aug. 31, 2025 P132: Identification of metabolic checkpoints during osteoclastogenesis and bone turnover March 1, 2024 - Aug. 31, 2025 P155-OA: Intestinal epithelial barrier disruption as the trigger to Prevotella-induced arthritis July 1, 2024 - June 30, 2025